A Randomized, Open-Label, Multicenter Comparative Study of the Efficacy and Safety of Piperacillin-Tazobactam and Cefepime for the Empirical Treatment of Febrile Neutropenic Episodes in Patients with Hematologic Malignancies.

Saved in:
Bibliographic Details
Title: A Randomized, Open-Label, Multicenter Comparative Study of the Efficacy and Safety of Piperacillin-Tazobactam and Cefepime for the Empirical Treatment of Febrile Neutropenic Episodes in Patients with Hematologic Malignancies.
Authors: Bow, E. J.1,2 ebow@hsc.mb.ca, Rotstein, C.3, Noskin, G. A.4, Laverdière, M.5, Schwarer, A. P.6, Segal, B. H.7, Seymour, J. F.8, Szer, J.9, Sanche, S.10
Source: Clinical Infectious Diseases. 8/15/2006, Vol. 43 Issue 4, p447-459. 13p.
Database: Environment Complete
Description
ISSN:10584838
DOI:10.1086/505393